Xun Deng1, Yong Cheng1, Xue-Mei Zhu1, Dan-Dan Linghu1, Hua Xu2, Jian-Hong Liang1. 1. Peking University People's Hospital, Eye Diseases and Optometry Institute, Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, Department of Ophthalmology & Clinical Centre of Optometry, College of Optometry, Peking University Health Science Center, Beijing 100044, China. 2. Department of Ophthalmology, Children's Hospital of Soochow University, Suzhou 215003, Jiangsu Province, China.
Abstract
AIM: To evaluate foveal vessel density (VD) and foveal thickness using optical coherence tomography angiography (OCTA) in retinopathy of prematurity (ROP) children treated with laser photocoagulation or anti-vascular endothelial growth factor (VEGF) injection. Additionally, we assessed the relationship between foveal microvascular anomalies and different therapies in ROP children. METHODS: This was a single-center, retrospective study of patients with a diagnosis of type 1 ROP. Twenty-three eyes (14 patients) treated with anti-VEGF injection and twenty-nine eyes (17 patients) treated with laser coagulation were included in this study. The foveal VD, inner thickness and full thickness were measured at the central 0°, 2° to 8°, and 8° of the retina (centered on the fovea) using OCTA and cross-sectional OCT, respectively. RESULTS: Foveal VD, inner thickness and full thickness were significantly smaller within the central 8° of the retina in ROP children treated with anti-VEGF injection than in those treated with laser photocoagulation (P=0.013, 0.009, 0.036, respectively). The full thickness was also smaller in the anti-VEGF group than in the laser group at the central 0° of the retina (P=0.010). The grade of foveal hypoplasia is lower in the anti-VEGF group than in the laser group (P=0.045). Multivariable analysis did not find any risk factors associated with visual acuity in our study. CONCLUSION: In children with type 1 ROP, the better structural development of fovea in those who were treated with anti-VEGF injection compared with laser photocoagulation are identified. However, visual acuity outcomes are similar 70mo after the treatments. International Journal of Ophthalmology Press.
AIM: To evaluate foveal vessel density (VD) and foveal thickness using optical coherence tomography angiography (OCTA) in retinopathy of prematurity (ROP) children treated with laser photocoagulation or anti-vascular endothelial growth factor (VEGF) injection. Additionally, we assessed the relationship between foveal microvascular anomalies and different therapies in ROP children. METHODS: This was a single-center, retrospective study of patients with a diagnosis of type 1 ROP. Twenty-three eyes (14 patients) treated with anti-VEGF injection and twenty-nine eyes (17 patients) treated with laser coagulation were included in this study. The foveal VD, inner thickness and full thickness were measured at the central 0°, 2° to 8°, and 8° of the retina (centered on the fovea) using OCTA and cross-sectional OCT, respectively. RESULTS: Foveal VD, inner thickness and full thickness were significantly smaller within the central 8° of the retina in ROP children treated with anti-VEGF injection than in those treated with laser photocoagulation (P=0.013, 0.009, 0.036, respectively). The full thickness was also smaller in the anti-VEGF group than in the laser group at the central 0° of the retina (P=0.010). The grade of foveal hypoplasia is lower in the anti-VEGF group than in the laser group (P=0.045). Multivariable analysis did not find any risk factors associated with visual acuity in our study. CONCLUSION: In children with type 1 ROP, the better structural development of fovea in those who were treated with anti-VEGF injection compared with laser photocoagulation are identified. However, visual acuity outcomes are similar 70mo after the treatments. International Journal of Ophthalmology Press.
Authors: John T McAllister; Adam M Dubis; Diane M Tait; Shawn Ostler; Jungtae Rha; Kimberly E Stepien; C Gail Summers; Joseph Carroll Journal: Vision Res Date: 2010-02-10 Impact factor: 1.886
Authors: Cassie A Ludwig; Tiffany A Chen; Tina Hernandez-Boussard; Andrew A Moshfeghi; Darius M Moshfeghi Journal: Ophthalmic Surg Lasers Imaging Retina Date: 2017-07-01 Impact factor: 1.300
Authors: Domenico Lepore; Graham E Quinn; Fernando Molle; Antonio Baldascino; Lorenzo Orazi; Maria Sammartino; Velia Purcaro; Carmen Giannantonio; Patrizia Papacci; Costantino Romagnoli Journal: Ophthalmology Date: 2014-07-04 Impact factor: 12.079
Authors: Anne C C Lee; Joanne Katz; Hannah Blencowe; Simon Cousens; Naoko Kozuki; Joshua P Vogel; Linda Adair; Abdullah H Baqui; Zulfiqar A Bhutta; Laura E Caulfield; Parul Christian; Siân E Clarke; Majid Ezzati; Wafaie Fawzi; Rogelio Gonzalez; Lieven Huybregts; Simon Kariuki; Patrick Kolsteren; John Lusingu; Tanya Marchant; Mario Merialdi; Aroonsri Mongkolchati; Luke C Mullany; James Ndirangu; Marie-Louise Newell; Jyh Kae Nien; David Osrin; Dominique Roberfroid; Heather E Rosen; Ayesha Sania; Mariangela F Silveira; James Tielsch; Anjana Vaidya; Barbara A Willey; Joy E Lawn; Robert E Black Journal: Lancet Glob Health Date: 2013-06-25 Impact factor: 26.763